Home » Topics » Regulatory

Regulatory
RSS

Foscavir approved in Japan to treat HHV-6 encephalitis

March 27, 2019

AnGes obtains conditional approval in Japan for HGF plasmid in critical limb ischemia

March 27, 2019

Revcovi approved in Japan for ADA deficiency

March 27, 2019

FDA approves Mayzent for relapsing forms of MS

March 27, 2019

Vyndaqel approved in Japan for transthyretin amyloid cardiomyopathy

March 26, 2019

Japan first to approve Skyrizi for psoriasis indications

March 26, 2019

Smyraf approved in Japan to treat rheumatoid arthritis

March 26, 2019

European Commission approves Forxiga for type 1 diabetes

March 25, 2019

FDA approves Sunosi for excessive daytime sleepiness associated with narcolepsy or OSA

March 21, 2019

FDA approves Zulresso for postpartum depression

March 20, 2019